These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31372030)

  • 1. Real-life management of patients with breakthrough cancer pain caused by bone metastases in Spain.
    Ferrer Albiach C; Villegas Estévez F; López Alarcón MD; de Madariaga M; Carregal A; Arranz J; Trinidad Martín-Arroyo JM; Jiménez López AJ; Sanz Yagüe A
    J Pain Res; 2019; 12():2125-2135. PubMed ID: 31372030
    [No Abstract]   [Full Text] [Related]  

  • 2. Current management of breakthrough cancer pain according to physicians from pain units in Spain.
    Estévez FV; Alarcón MDL; Mayoral V; de Madariaga M; Margarit C; Duran JA; Martín-Arroyo JMT; Carregal A;
    Clin Transl Oncol; 2019 Sep; 21(9):1168-1176. PubMed ID: 30783918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakthrough cancer pain treatment in Spain: physicians' perception of current opioids utilization and prescription.
    Villegas Estévez F; López Alarcón MD; Alonso Babarro A; Olay Gayoso L; de Castro J; Lería-Gelabert M; Melogno-Klinkas M
    Curr Med Res Opin; 2020 Aug; 36(8):1383-1391. PubMed ID: 32453602
    [No Abstract]   [Full Text] [Related]  

  • 4. Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer.
    Magnani C; Giannarelli D; Calvieri A; Dardeli A; Eusepi G; Restuccia MR; Mastroianni C; Casale G
    Postgrad Med J; 2018 Oct; 94(1116):566-570. PubMed ID: 30317182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study.
    Villarroel PG; Padró JG; Marquina G; Jáñez NM; González EE; Antón A; Sánchez MB; Cáceres AR; López-López R; Cornejo RE; García PB; Fabregat RM; Fernández BC; Bermudo CL; Camps C
    Future Oncol; 2022 Nov; 18(35):3913-3927. PubMed ID: 36537885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
    Mercadante S; Caraceni A; Masedu F; Scipioni T; Aielli F
    Oncologist; 2020 Feb; 25(2):156-160. PubMed ID: 31862860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study.
    Mercadante S; Adile C; Masedu F; Marchetti P; Costanzi A; Aielli F
    Eur J Pain; 2019 Apr; 23(4):719-726. PubMed ID: 30421474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expert consensus on the management of breakthrough cancer pain in older patients. A Delphi study.
    Alarcón MDL; Estévez FV; Cabezón-Gutiérrez L; Padrós MC; Martín-Arroyo JMT; Rebollo MA; Jiménez-López AJ; Sanz-Yagüe A
    J Geriatr Oncol; 2019 Jul; 10(4):643-652. PubMed ID: 31036463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian recommendations for the management of breakthrough cancer pain.
    Daeninck P; Gagnon B; Gallagher R; Henderson JD; Shir Y; Zimmermann C; Lapointe B
    Curr Oncol; 2016 Apr; 23(2):96-108. PubMed ID: 27122974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of sublingual fentanyl vs. oral morphine for cancer-related breakthrough pain.
    Velázquez Rivera I; Muñoz Garrido JC; García Velasco P; España Ximénez de Enciso I; Velázquez Clavarana L
    Adv Ther; 2014 Jan; 31(1):107-17. PubMed ID: 24385406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough cancer pain: The importance of the right treatment at the right time.
    O'Hagan P; Mercadante S
    Eur J Pain; 2018 Aug; 22(7):1362-1374. PubMed ID: 29635732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON).
    Porta-Sales J; Pérez C; Escobar Y; Martínez V
    Clin Transl Oncol; 2016 Sep; 18(9):945-54. PubMed ID: 26693731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS.
    Masel EK; Landthaler R; Gneist M; Watzke HH
    Support Care Cancer; 2018 Feb; 26(2):491-497. PubMed ID: 28849261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment.
    Cortesi PA; D'Angiolella LS; Vellucci R; Allegri M; Casale G; Favaretti C; Kheiraoui F; Cesana G; Mantovani LG
    PLoS One; 2017; 12(6):e0179523. PubMed ID: 28654672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge and practice of the management of breakthrough cancer pain among general practitioners providing palliative care in Shanghai, China: a cross-sectional survey.
    Yu Y; Zhang P; Chen D; Jiang SF
    BMJ Open; 2023 Sep; 13(9):e073670. PubMed ID: 37770268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usability, Acceptability, and Usefulness of an mHealth App for Diagnosing and Monitoring Patients With Breakthrough Cancer Pain.
    Boceta J; Samper D; de la Torre A; Sánchez-de la Rosa R; González G
    JMIR Cancer; 2019 Apr; 5(1):e10187. PubMed ID: 30932862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials.
    Jandhyala R; Fullarton JR; Bennett MI
    J Pain Symptom Manage; 2013 Oct; 46(4):573-80. PubMed ID: 23380337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain.
    Ueberall MA; Lorenzl S; Lux EA; Voltz R; Perelman M
    J Pain Res; 2016; 9():571-85. PubMed ID: 27574463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of breakthrough pain on community-dwelling cancer patients: results from the National Breakthrough Pain Study.
    Katz NP; Gajria KL; Shillington AC; Stephenson JJ; Harshaw Q
    Postgrad Med; 2017 Jan; 129(1):32-39. PubMed ID: 27846789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' Satisfaction with Breakthrough Cancer Pain Therapy: A Secondary Analysis of IOPS-MS Study.
    Mazzotta M; Filetti M; Piras M; Mercadante S; Marchetti P; Giusti R
    Cancer Manag Res; 2022; 14():1237-1245. PubMed ID: 35356594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.